How do I manage stage four metastatic bladder cancer?

Question

Hello doctor,

I was diagnosed with muscle-invasive bladder cancer eleven months ago. I underwent radical cystectomy with an ileal conduit and completed adjuvant chemotherapy. However, recent surveillance CT and bone scans show that the cancer has spread extensively to the lymph nodes, liver, lungs, and spine.

I am experiencing severe fatigue, progressive weight loss of thirty-eight pounds over four months, persistent bone pain in the spine and pelvis, shortness of breath, and occasional confusion.

My oncologist has explained that this is stage four metastatic disease that is incurable but treatable. I am devastated about the prognosis and the time left with my family.

What treatment options are available?
What are the response rates?
What is a realistic life expectancy?
How should quality of life versus length of life be balanced?
What side effects can be expected from treatment?
When should treatment be stopped?
Should clinical trials be considered?
When is hospice care appropriate?
How can my family be prepared for what lies ahead?

Kindly advise.

Answer 1

Hello,

Welcome to icliniq.com.

I understand your concern.

I am sorry that this situation is being faced. With widespread metastatic urothelial cancer and significant symptoms such as bone pain, breathlessness, and confusion, the main priorities are symptom relief and choosing treatment that aligns with personal goals of care. Treatment options depend on prior exposure to platinum-based chemotherapy, kidney function, and tumor-related markers.

Common next-line options include immunotherapy, such as Pembrolizumab or Nivolumab, antibody–drug conjugates like Enfortumab vedotin, and chemotherapy in patients who are fit enough to tolerate it. Treatment responses vary. Some patients achieve disease control for several months, while a smaller group experiences longer benefit. The treating oncologist can provide a more individualized estimate based on performance status and laboratory results.

Potential side effects should be carefully considered. Immunotherapy can cause immune-mediated inflammation affecting the skin, gastrointestinal tract, lungs, liver, or thyroid gland. Enfortumab vedotin may cause peripheral neuropathy, skin rashes or severe skin reactions, and elevated blood sugar levels.

Chemotherapy is commonly associated with infections, fatigue, hair loss, and neuropathy. For bone pain, palliative radiation therapy, adequate pain control with analgesics, and bone-strengthening agents may be appropriate. Confusion requires urgent evaluation to rule out causes such as high calcium levels, infection, medication effects, or brain metastases.

Treatment is usually stopped when side effects outweigh benefits, imaging shows disease progression despite multiple treatment lines, or when comfort-focused care is preferred. Clinical trials should be discussed at this stage, as they may provide access to newer therapies.

Hospice care is appropriate when life expectancy is estimated to be less than or equal to six months or when the focus shifts entirely to comfort and home-based care. Early involvement of palliative care is strongly recommended, as it can be provided alongside active treatment. Family preparation should include clear discussions about goals of care, advance directives, practical planning, and access to psychological and social support services.

I hope you are satisfied with my answer. For further queries, you can consult me at iCliniq.

Thank you.